Bloodstream Infections
📧 Sign up to get email alerts when something new happens for Bloodstream Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: INfectious DIsease REgistry BIObank
This entry (NCT06418048) for the Infectious Disease Registry Biobank indicates the study is currently recruiting, sponsored by IRCCS San Raf…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
This update reports on a completed clinical trial evaluating antibiotic-resistant Enterobacterales bloodstream infections and risk factors i…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard
This trial update reports on the clinical impact of rapid identification of positive blood cultures compared with the internal laboratory st…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI [Phase 2]
Phase 2 randomized trial comparing cefiderocol to best available therapy for bloodstream infections has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response [Phase 4]
A Phase 4 trial comparing meropenem to piperacillin-tazobactam in bloodstream infection, assessing mortality and clinical response.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens [Phase 3]
Phase 3 trial evaluating Cefiderocol (S-649266) versus best available therapy for severe infections due to carbapenem-resistant Gram-negativ…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants [NA]
Completed clinical trial evaluating enteral glutamine for reducing bloodstream infections in infants with short bowel syndrome; results post…
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections [NA]
The trial evaluating topical antibiotics to prevent ICU central line-associated bloodstream infections has been withdrawn.